Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-7 immunotherapy.

Claude Sportès1, Ronald E Gress

  • 1Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. csportes@mail.nih.gov

Advances in Experimental Medicine and Biology
|August 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disruption of Notch signaling by KGF induces a developmental pause in thymocytes.

Frontiers in immunology·2025
Same author

In vivo deuterium magnetic resonance imaging of xenografted tumors following systemic administration of deuterated water.

Research square·2025
Same author

Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT.

Blood·2025
Same author

High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention.

Blood advances·2024
Same author

Microbial ligand-independent regulation of lymphopoiesis by NOD1.

Nature immunology·2023
Same author

In vivo deuterium magnetic resonance imaging of xenografted tumors following systemic administration of deuterated water.

Scientific reports·2023

Interleukin-7 (IL-7) is crucial for T cell homeostasis and shows promise as an immunotherapy. Early human trials in patients with incurable cancers indicate its potential as a therapeutic agent.

Area of Science:

  • Immunology
  • Cell Biology
  • Medical Research

Background:

  • Interleukin-7 (IL-7) is a cytokine belonging to the common gamma-chain family.
  • IL-7 plays a key role in immune development and T cell homeostasis.
  • Its function in postdevelopment thymic activity is debated, but its immune-enhancing properties are significant.

Purpose of the Study:

  • To evaluate the potential of IL-7 as an immunotherapeutic agent.
  • To investigate the in vivo effects of IL-7 in humans.
  • To explore IL-7's role in clinical settings, particularly in oncology.

Main Methods:

  • Phase I clinical trial involving subjects with incurable malignancy.
  • Administration of IL-7 in a human cohort.
  • Analysis of human in vivo data from the National Cancer Institute study.

Related Experiment Videos

Main Results:

  • IL-7 is emerging as a promising immunotherapeutic agent based on preclinical and early human data.
  • The study provides human in vivo data on IL-7's effects.
  • Preclinical data from murine and simian models support IL-7's therapeutic potential.

Conclusions:

  • IL-7's role in T cell homeostasis makes it an attractive candidate for immunotherapy.
  • Human phase I trials are underway, showing promise for IL-7 as a therapeutic agent.
  • Further research is warranted to define IL-7's role in postdevelopment thymic function and its broader clinical applications.